Skip to main content

Table 1 General description and univariate analysis of variables under study

From: Predicting treatment failure in patients with community acquired pneumonia: a case-control study

Variable (N, %)

CAP non-failure N = 170

Early failure N = 40

p value**

Late failure N = 43

p value***

Age, mean (SD)

67.2 (17.6)

67.4 (18.5)

0.8

69.0 (15.8)

0.8

Gender, male

116 (68.6)

26 (65)

0.6

24 (55.8)

0.1

Smoking habit

31 (18.3)

8 (20)

0.8

13 (30.2)

0.08

Alcohol intake

17 (10.1)

4 (10)

0.9

5 (11.6)

0.7

Pulmonary diseases

66 (39.1)

18 (45)

0.4

23 (53.3)

0.08

COPD

31 (18.3)

6 (15)

0.6

7 (16.3)

0.8

Previous Antibiotic therapy

61 (36.1)

19 (47.5)

0.1

11 (25.6)

0.2

Previous hospitalization

33 (19.5)

7 (17.5)

0.8

7 (16.3)

0.6

Previous CAP

48 (28.4)

8 (20)

0.3

9 (20.9)

0.3

Comorbidity (all)

93 (54.7)

15 (37.5)

0.05

24 (55.8)

0.9

Neurological

47 (27.7)

9 (22.5)

0.5

13 (30.2)

0.7

Cirrhosis

5 (2.9)

1 (2.5)

0.8

2 (4.7)

0.6

Cardiac insufficiency

33 (19.4)

4 (10.0)

0.2

11 (25.6)

0.4

Chronic Renal failure

14 (8.3)

1 (2.5)

0.2

1 (2.3)

0.2

Diabetes Mellitus

39 (22.9)

7 (17.5)

0.5

7 (16.3)

0.3

Digestive

34 (20.0)

8 (18.6)

0.8

7 (17.5)

0.7

Multilobar involvement

34 (20.0)

23 (53.5)

< 0.001

14 (35.0)

0.04

ICU admission

5 (3)

6 (15)

0.002

24 (55.8)

< 0.001

PSI IV-V

108 (63.9)

22 (55)

0.3

34 (79.1)

0.06

CURB 65 ≥ 3

50 (29.4)

14 (35.0)

0.6

22 (51.2)

0.004

Pleural effusion

24 (14.1)

13 (32.5)

0.006

9 (20.9)

0.3

Mortality

3 (1.8)*

13 (32.5)

< 0.001

14 (32.6)

< 0.001

Length of hospital stay, mean (SD)

8.1 (5.7)

17.5 (10.5)

< 0.001

17.1 (17.1)

< 0.001

Pneumococcal pneumonia

28 (16.5)

8 (20.0)

0.6

8 (18.6)

0.7

  1. *Patients included in this category; mortality was not directly attributed to the pneumonia and occurred > 96 h, after admission.
  2. **p value comparing early failure cases with control group (non-failure CAP patients).
  3. ***p value comparing late failure cases with control group (non-failure CAP patients).